Instance: Elvanse-50mg-Capsule-SE-AJ-RegulatedAuthorization
InstanceOf: PPLRegulatedAuthorization
Usage: #inline
* meta.versionId = "1"
* meta.lastUpdated = "2022-08-09T14:17:27.17+00:00"
* identifier.system = "http://ema.europa.eu/fhir/marketingAuthorizationNumber"
* identifier.value = "47383"
* subject = Reference(Elvanse-50mg-Capsule-SE-AJ-MedicinalProductDefinition)
* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000535 "Sweden"
* status = $100000072049#100000072099 "Valid"
* statusDate = "2013-07-22"
* holder.identifier.system = "https://spor.ema.europa.eu/v1/locations"
* holder.identifier.value = "LOC-100011567"
* holder.display = "Shire Pharmaceuticals Ireland Limited"
* case.type = $authorisationDateType#dateOfFirstAuthorisation "First Authorisation"
* case.dateDateTime = "2013-07-22"